Lipolytic Injectables: The Complete Practitioner's Guide
Injectable lipolytics — agents that chemically destroy subcutaneous fat cells — represent one of the most technically specific and outcome-dependent treatments in non-surgical aesthetic medicine. When patient selection is correct, the treatment zone is appropriate, the product and protocol are sound, and the patient's expectations are accurately set, injectable lipolytics produce permanent, visible, and highly valued results. When any of these elements is wrong, the risk of adverse outcomes — prolonged swelling, irregular contour, nerve injury — increases substantially.
Korean PDRN Products: A Practitioner's Guide to Selection and Use
South Korea is the world's leading producer of pharmaceutical-grade PDRN injectables. The Korean PDRN industry has been developing, manufacturing, and exporting these products for over two decades — a timeline that gives Korean manufacturers an accumulated clinical knowledge base and manufacturing expertise that no other country's PDRN industry can currently match. For UK and EU practitioners, this means the best available PDRN products are, almost without exception, Korean in origin.
PDRN vs HA Skin Boosters: Which Is Right for Your Patient?
As PDRN (polydeoxyribonucleotide) products enter mainstream aesthetic practice, one of the most common questions practitioners ask is deceptively simple: for a given patient, should I use PDRN or a HA skin booster? The question is deceptive because it implies a binary choice where the more useful clinical framing is a spectrum — with most patients sitting somewhere in the middle where both could offer benefit, and the skill lying in knowing which mechanism addresses their dominant concern more directly.
Polynucleotides and PDRN: The Complete Practitioner's Guide
Polynucleotides — sold under a variety of brand names and delivered through a growing range of injection products — have become one of the most talked-about categories in UK aesthetic medicine. They are also one of the most misunderstood. Practitioners encounter them under different terminology (PDRN, PN, polynucleotide, polydeoxyribonucleotide), from multiple manufacturers, with variable claimed mechanisms, and with an evidence base that ranges from well-established to preliminary depending on the specific application and product.
Profhilo vs Korean Skin Boosters: A Clinical Product Comparison
Profhilo (IBSA, Italy) changed the UK skin booster market when it launched in 2015. Its innovative thermal hybridisation technology, high HA concentration, and elegantly simple 5-point injection protocol made it the reference product against which all subsequent biorevitalisation treatments have been measured. For many UK practitioners, Profhilo is the skin booster — the product they trained on, the one their patients know by name, and the one on which their protocols are built.
Botulax vs Nabota vs Bocouture vs Dysport: Which Toxin Should Your Clinic Stock?
The botulinum toxin market has expanded significantly over the past decade. Where UK and European practitioners once had a limited choice of two or three products, today's market offers a growing range of formulations from manufacturers in South Korea, Germany, France, and the United States — each with different protein loads, unit strengths, onset profiles, and price points.
